Lab Test for Acute Head Injury (TBI) - Banyan and TBI Conference - more detail
From the agenda page of the conference that takes place in March....
2:55 Blood Based Analysis of Biomarkers for Acute and Chronic Diagnosis of TBI Currently Banyan Biomarkers, Inc. is conducting a pivotal trial to secure the first FDA approval for serum biomarkers useful in the acute diagnosis of TBI. This talk will review strategies for discovery and validation of biomarkers of brain injury, including acute TBI. The lecture will also cover the development of novel antibody-based biomarkers potentially useful for diagnosis of TBI in the chronic phase following phase injury.
Ronald L. Hayes, Ph.D., Founder & President, Banyan Biomarkers
Note: another way to say "pivotal trial to secure the first FDA approval for serum biomarkers useful in the acute diagnosis of TBI" is:
"Pivotal trial, that if successful, means approval to market a blood test that diagnoses concussion (traumatic brain injury, TBI)."